TBPH Theravance Biopharma, Inc.

8-K Current Report

Filed: March 19, 2026

Health Care

Pharmaceutical Preparations

Theravance Biopharma, Inc. (TBPH) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Item 2.02 reference indicates earnings or financial results disclosed via Exhibit 99.1
• No specific financial figures or period details provided in the text itself

+2 more insights

Other Theravance Biopharma, Inc. 8-K Filings

8-K Mar 3, 2026

Get deeper insights on Theravance Biopharma, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.